Author

Jiantao Bian

University of UtahORCID 0000-0001-5989-5177Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:electronic health records· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1 Approach:simulation· 1

Frequent Co-Authors

Benjamin Robert tenOeveriD· 2 shared Daisy A. HoaglandiD· 2 shared Gabriel E. HoffmaniD· 2 shared Georgios VoloudakisiD· 2 shared James M. VicariiD· 2 shared Jennifer S. LeeiD· 2 shared John F. FullardiD· 2 shared Julie Ann LynchiD· 2 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Benjamin Robert tenOeverORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintJan 10, 2025

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19

Georgios Voloudakis, Kyung Min Lee, James M. Vicari…·Panos Roussos

This paper presents a computational drug repurposing framework that identifies FDA-approved drugs for COVID-19 by integrating genetic expression data and EMR data, finding four compounds with protective effects in validation.

3 citations

humanelectronic health records

𝕏 PostBluesky

Genetic & Genomic Medicinenpj Genomic MedicinePeer-reviewedSep 5, 2022

IL10RB as a key regulator of COVID-19 host susceptibility and severity

Georgios Voloudakis, James M. Vicari, Sanan Venkatesh…·Panos Roussos

The paper identifies IL10RB as a key regulator of COVID-19 host susceptibility and severity through integrative analysis of genetic and transcriptomic data, and validates potential drug repositioning candidates.

25 citations

humanbulk RNA-seq

𝕏 PostBluesky